Circulation

JANUARY 12, 2025

Circulation, Volume 151, Issue 2 , Page 193-195, January 14, 2025.

Coronary Artery Disease 49

Coronary Artery Disease Outcomes Circulation 49

Cardiometabolic Health Congress

JANUARY 16, 2025

Key strategies include: Polygenic Risk Scores: Identifying Risk Early PRS helps identify young adults at high lifetime risk for coronary artery disease (CAD). A 2022 study published in Circulation demonstrated that earlier LDL-C reduction leads to compounded cardiovascular benefits over time.

Atherosclerosis 59

Atherosclerosis Risk Factors Coronary Artery Disease Cardiovascular Disease 59

Circulation: Genomic and Precision Medicine

JANUARY 24, 2025

Circulation: Genomic and Precision Medicine, Ahead of Print. BACKGROUND:Earlier identification of high coronary artery disease (CAD) risk individuals may enable more effective prevention strategies. However, existing 10-year risk frameworks are ineffective at earlier identification.

Coronary Artery Disease 40

Coronary Artery Disease Risk Factors Circulation 40

American College of Cardiology

APRIL 16, 2025

Individuals with a high genetic risk for coronary artery disease (CAD) also have an increased risk of developing dementia, according to a large UK population study published April 4 in Circulation.

Dementia 48

Dementia Coronary Artery Disease Circulation Article 48

Circulation: Cardiovascular Interventions

APRIL 2, 2025

Circulation: Cardiovascular Interventions, Ahead of Print.

Coronary Artery Disease 40

Coronary Artery Disease Angioplasty Cardiovascular Interventions Circulation 40

Circulation

JUNE 30, 2024

Circulation, Volume 150, Issue 1 , Page e3-e4, July 2, 2024.

Coronary Artery Disease 49

Coronary Artery Disease Angina Article Circulation 49

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4136459-A4136459, November 12, 2024. Introduction:Patients with Type 2 diabetes mellitus (T2DM) have an increased risk for coronary artery disease (CAD) compared to patients without T2DM.

Coronary Artery Disease 40

Coronary Artery Disease Arrhythmia Diabetes Tachycardia 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144277-A4144277, November 12, 2024. However, the long-term outcomes in patient with an intermediate stenosis received FFR have not yet been investigated comprehensively.Methods:We retrospective included 558 patients underwent both coronary artery angiography (CAG) and FFR.

Coronary Artery Disease 40

Coronary Artery Disease Stenosis Risk Factors Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4143220-A4143220, November 12, 2024. We evaluated patterns of evidence-based prescription of SGLT2i and GLP1RA over time and by race in US Veterans with T2D and coronary artery disease (CAD).Results:Of

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Circulation Outcomes 40

Circulation

FEBRUARY 13, 2024

Circulation, Ahead of Print. BACKGROUND:Vascular calcification, which is characterized by calcium deposition in arterial walls and the osteochondrogenic differentiation of vascular smooth muscle cells, is an actively regulated process that involves complex mechanisms.

Coronary Artery Disease 80

Coronary Artery Disease Kidney Disease Aortic Plaque 80

Circulation

OCTOBER 5, 2023

Circulation, Ahead of Print. BACKGROUND:We investigated the usefulness of invasive coronary function testing to diagnose the cause of angina in patients with no obstructive coronary arteries.METHODS:Outpatients referred for coronary computed tomography angiography in 3 hospitals in the United Kingdom were prospectively screened.

Angina 40

Angina Coronary Artery Disease Circulation Hospital 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4143007-A4143007, November 12, 2024. Background:Myocardial infarction with nonobstructive coronary artery disease (MINOCA) is a special syndrome with clear evidence of myocardial ischemia, but no clear stenosis of coronary artery imaging sign.

Coronary Artery Disease 40

Coronary Artery Disease Atrial Fibrillation Myocardial Infarction Ischemia 40

Circulation: Genomic and Precision Medicine

SEPTEMBER 27, 2023

Circulation: Genomic and Precision Medicine, Volume 16, Issue 5 , Page 442-451, October 1, 2023. Background:Patients with de novo chest pain, referred for evaluation of possible coronary artery disease (CAD), frequently have an absence of CAD resulting in millions of tests not having any clinical impact.

Chest Pain 40

Chest Pain Coronary Artery Disease Risk Factors Circulation 40

Circulation

DECEMBER 27, 2023

Circulation, Volume 149, Issue 1 , Page 24-27, January 2, 2024.

Coronary Artery Disease 45

Coronary Artery Disease Angina Circulation 45

Stroke Journal

JANUARY 30, 2025

variants in the vicinity (300 kb) of theADIPOQgene from a GWAS of circulating adiponectin levels (n=~38,600). Higher genetically-proxied,ADIPOQ-mediated circulating adiponectin levels were associated with lower WMH (IVW =-0.131 per g/ml increase in adiponectin levels; 95% CI: (-0.217) - (-0.044); p=0.003) and CAD (IVW OR 0.93

Pharmacology 40

Pharmacology Circulation Coronary Artery Disease Risk Factors 40

DAIC

MARCH 28, 2024

"This pivotal study was performed in two different international populations which shows that CCTA analyzed with the Cleerly AI-QCT ISCHEMIA device provides an accurate assessment of coronary ischemia,” said James P. Circulation. Earls, MD , Chief Medical Officer of Cleerly. Gulati M, Levy PD, Mukherjee D, et al.

Ischemia 110

Ischemia Chest Pain Atherosclerosis Coronary Artery Disease 110

Dr. Smith's ECG Blog

MAY 19, 2020

MINOCA: Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease). Here is my comment on MINOCA: "Non-obstructive coronary disease" does not necessarily imply "no plaque rupture with thrombus." 2) overlooked obstructive coronary disease (e.g., What is MINOCA? myocarditis).

Defibrillator 52

Defibrillator Circulation Plaque Cardiac Arrest 52

Circulation: Genomic and Precision Medicine

JULY 6, 2023

Circulation: Genomic and Precision Medicine, Volume 16, Issue 5 , Page 480-482, October 1, 2023.

Coronary Artery Disease 40

Coronary Artery Disease Cholesterol Atherosclerosis Circulation 40

DAIC

JANUARY 15, 2024

FDA Breakthrough Device Designation recognizes novel innovations that demonstrate the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases. Circulation. For more information: [link] References: 1 Maurer M, Elliott P, Comenzo R, et al. 135(14):1357-1377. 2 Siddiqi O.,

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

Circulation

MARCH 10, 2024

Circulation, Volume 149, Issue 11 , Page 892-893, March 12, 2024.

Coronary Artery Disease 45

Coronary Artery Disease Article Circulation 45

Circulation

MARCH 10, 2024

Circulation, Volume 149, Issue 11 , Page 896-896, March 12, 2024.

Coronary Artery Disease 45

Coronary Artery Disease Article Circulation 45

Circulation

DECEMBER 28, 2023

Circulation, Ahead of Print. Using mediation Mendelian randomization, we explored proteomic mediators of the effects of genetically proxied IL-6 signaling on coronary artery disease, large artery atherosclerotic stroke, and peripheral artery disease.

Atherosclerosis 49

Atherosclerosis Peripheral Arterial Disease Coronary Artery Disease Pharmacology 49

American College of Cardiology

JUNE 26, 2024

Icosapent ethyl (IPE) treatment may be associated with a numerically lower risk of cardiovascular events, but this reduction did not reach statistical significance in patients with chronic coronary artery disease (CAD) and a low ratio of eicosapentaenoic acid to arachidonic acid (EPA/AA) on statin treatment, according to the results of the RESPECT-EPA (..)

Coronary Artery Disease 40

Coronary Artery Disease Outcomes Circulation Article 40

American College of Cardiology

FEBRUARY 1, 2025

Self-reported adherence to cardiovascular medications in patients who have coronary artery disease is for the combination of aspirin, beta-blocker and a lipid-lowering agent in surveys.7 Circulation. Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

Circulation

MARCH 10, 2024

Circulation, Volume 149, Issue 11 , Page 894-895, March 12, 2024.

Coronary Artery Disease 40

Coronary Artery Disease Article Circulation 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4119169-A4119169, November 12, 2024. The patient showed dramatic improvement and was discharged home on oral medications.Discussion:Treating multi-vessel coronary artery disease and CTO is challenging. PCI was successful with the use of the Carlino technique: 0.5

Coronary Artery Disease 40

Coronary Artery Disease Chest Pain Myocardial Infarction Thrombolysis 40

Frontiers in Cardiovascular Medicine

OCTOBER 13, 2024

ObjectiveThe present study aimed at evaluating the association between sympathetic nervous system activation (SNS) and the severity of coronary artery disease (CAD). SYNTAX I score was calculated based on coronary angiography. Systemic activation of the SNS was estimated through circulating levels of norepinephrine (NE).

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Atherosclerosis Biomarkers Coronary Artery Disease 52

Dr. Paddy Barrett

FEBRUARY 27, 2024

mmol/l (130 mg/dl) or below, between 20-50% will already have coronary artery disease. As HBA1c increases, even in the normal range, the probability of coronary artery disease increases. Circulation. For HBA1c, the trend is similar. Remember, these are all in the ‘normal’ range.

Risk Factors 111

Risk Factors Heart Disease Heart Attack Heart attacks 111

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4145973-A4145973, November 12, 2024.

Coronary Artery Disease 40

Coronary Artery Disease Circulation 40

Circulation: Cardiovascular Imaging

FEBRUARY 17, 2025

Circulation: Cardiovascular Imaging, Ahead of Print. The clinical spectrum of radiation-induced cardiovascular toxicity is broad, encompassing coronary artery disease, myocardial dysfunction, valvular abnormalities, and pericardial disorders.

Coronary Artery Disease 40

Coronary Artery Disease Cancer Cardiovascular Imaging Circulation 40

BoardVitals - Cardiovascular

JUNE 14, 2017

In preparation for the ABIM Cardiovascular Disease exam, check out the BoardVitals Cardiology Board Review Question Bank and we’ll make sure you’re well versed in the following 13 areas covered on the exam: Multiple-Choice Component Arrhythmias 15% Coronary Artery Disease 23% Heart Failure and Cardiomyopathy 17% Valvular Disease 15% Pericardial (..)

Congenital Heart Disease 52

Congenital Heart Disease Coronary Angiogram Coronary Artery Disease Cardiovascular Disease 52

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4140682-A4140682, November 12, 2024. Patients usually have a normal life expectancy unless other structural heart diseases are present. Introduction:Dextrocardia is a rare congenital condition where the heart's apex points to the right, with an incidence of about 0.01%.

Coronary Artery Disease 40

Coronary Artery Disease Angioplasty Anatomy Angina 40

Circulation

JANUARY 15, 2024

Circulation, Volume 149, Issue 3 , Page 251-266, January 16, 2024. Coronary artery calcification (CAC) accompanies the development of advanced atherosclerosis.

Coronary Artery Disease 45

Coronary Artery Disease Atherosclerosis Laboratory Plaque 45

Circulation: Heart Failure

DECEMBER 18, 2023

Circulation: Heart Failure, Ahead of Print. BACKGROUND:Coronary microvascular dysfunction (CMD) is involved in heart failure (HF) onset and progression, independently of HF phenotype and obstructive coronary artery disease.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Coronary Artery Disease Circulation 40

BoardVitals - Cardiovascular

JULY 26, 2022

The exam covers the following topics: Arrhythmias 15% Coronary Artery Disease 21.5% Heart Failure and Cardiomyopathy 19% Valvular Disease 15% Pericardial Disease 3% Congenital Heart Disease 3% Vascular Diseases 5% Systemic Hypertension and Hypotension 8.5%

Congenital Heart Disease 52

Congenital Heart Disease Certification Coronary Artery Disease Congenital 52

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4122763-A4122763, November 12, 2024. Background:The impact of antianginal therapies on the health status of coronary artery disease (CAD) patients who have undergone coronary revascularization has not been extensively researched.

Coronary Artery Disease 40

Coronary Artery Disease Outcomes Angina Circulation 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4141524-A4141524, November 12, 2024. Results::Coronary artery disease was the primary indication in 87% of cases. At the end of the program, there was a significant improvement in knowledge of the disease (4.5 p <0.001) and its treatment (4.7 p <0.001).Conclusion:Results

Education 40

Education Cardiac Rehabilitation Cardiovascular Disease Coronary Artery Disease 40